HealthDay News — Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published in the Annals of the Rheumatic ...

Patients share what they wish they had known before getting a diagnosis of a chronic inflammatory condition called psoriatic ...

Fact checked by Nick Blackmer When I was diagnosed with psoriatic arthritis in 2020, I felt one thing: anger. I’d been living ...

Dr. Ogdie: People with a lot of joint swelling tend to have an all-over pain that comes and goes, and typically, the pain improves with treatment of the psoriatic arthritis. But it can be ...

The clinical presentation of psoriatic arthritis varies dramatically across patients, creating diagnostic challenges that often delay proper treatment. The hallmark skin plaques present as ...

In a study of more than 600 psoriatic arthritis (PsA ... an electronic health records-based pragmatic trial to evaluate treatment responses in PsA [based on these clusters]." ...

Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...

Delays in diagnosing and treating psoriatic ... as the treatments people are receiving. The results confirm a suspicion long held by the authors: that early symptoms of psoriatic arthritis ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic arthritis, as well as progression of structural damage, according to new phase 3 ...